Prostate cancer: Value of magnetic resonance spectroscopy 3D chemical shift imaging

Abdominal Imaging

Volumn 31, Issue 4, 2006, Pages 490-499

  Casciani, Emanuele ^a   Gualdi, Gian Franco ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Cancer; MRI; Prostate; Prostatitis; Spectroscopy

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CELL METABOLISM; HIGH RISK PATIENT; HUMAN; METABOLIC DISORDER; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

BIOPSY, NEEDLE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 33847680194     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-006-9029-8     Document Type: Review

References (51)

1. Jemal A, Murray T, Ward E, et al. (2005) Cancer statistics. CA Cancer J Clin 55:10-30
2. Blute ML, Bergstralh EJ, Iocca A, et al. (2001) Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 165:119-125
3. Han M, Partin AW, Zahurak M, et al. (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169:517-523
4. Shipley WU, Thames HD, Sandler HM, et al. (1999) Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281:1598-1604
5. Sandler HM, Dunn RL, McLaughlin PW, et al. (2000) Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 48:629-633
6. Lu-Yao GL, Yao SL (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349:906-910
7. Holmberg L, Bill-Axelson A, Helgensen F, et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347:781-789
8. Augustin H, Eggert T, Wenske S, et al. (2004) Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathologic stage in clinically localized prostate cancer. J Urol 171:177-181
9. Cookson MS, Fleshner NE, Soloway SM, et al. (1997) Correlation between Gleason score of needle biopsy and radical prostatectomy specimens: accuracy and clinical implications. J Urol 157:559-562
10. Costello LC, Franklin RB (1991) Concepts of citrate production and secretion by prostate. I. Metabolic relationships. Prostate 18:25-46
11. Khan T, Beurrig K, Schmitz-Dreager B, et al. (1989) Prostatic carcinoma and benign prostatic hyperplasia. Radiology 173:847-851
12. Costello LC, Franklin RB (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 35:285-296
13. Liang JY, Liu YY, Zou J, et al. (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40:200-207
14. Rajesh A, Caokley FV (2004) MR imaging and MR spectroscopy imaging of prostate cancer. Magn Reson Imaging Clin North Am 12:557-579
15. Heston WD (1991) Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv 11:217-238
16. 3) spatial resolution. Radiology 198:795-805
17. Jung JA, Coakley FV, Vigneron DB, et al. (2004) Prostate depiction at endorectal mr spectroscopic imaging: investigation of a standardized evaluation system. Radiology 233:701-708
18. Presti JC, Hricak H, Narayan PA, et al. (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR 166:103-108
19. Jager GJ, Ruijter ET, Van de Kaa CA, et al. (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 166:845-852
20. Hricak H, White S, Vigneron D, et al. (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703-709
21. Schiebler M, Schnall MD, Pollack HM, et al. (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339-352
22. White S, Hricak H, Forstner R, et al. (1995) Prostate cancer: effect of postbiopsy haemorrhage on interpretation of MR images. Radiology 195:385-390
23. Quint LE, Van Erp JS, Bland PH, et al. (1991) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumour volume. AJR 156:511-516
24. Scheidler J, Hricak H, Vigneron DB, et al. (1991) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging- clinicopathologic study. Radiology 213:473-480
25. Yu KK, Scheidler J, Hricak H, et al. (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481-488
26. Wefer AE, Hricak H, Vigneron DB, et al. (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400-404
27. Casciani E, Polettini E, Pansadoro V, et al. (2005) Prostate cancer: evaluation with endorectal MR imaging and 3D proton MR spectroscopic imaging. Abstract. RSNA
28. Kurhanewicz J, Vigneron DB, Males RG, et al. (2000) The prostate: MR imaging and spectroscopy-present and future. Radiol Clin North Am 38:115-138
29. Shukla-Dave Amita, Hedvig Hricak D, Eberhardt SC, et al. (2004) Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings - initial observations. Radiology 231:717-724
30. Casciani E, Polettini E, Bertini L, et al. (2005) Granulomatous prostatitis: a pitfall in endorectal MR imaging and 3D MR spectroscopic imaging. Eur J Radiol 54:111-114
31. Kaji Y, Kurhanewicz J, Hricak H, et al. (1998) Localizing prostate cancer in the presence of post-biopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 206:785-790
32. Prando A, Kurhanewicz J, Borges AP, et al. (2005) Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236:903-910
33. Yuen JS, Thng CH, Tan PH, et al. (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171:1482-1486
34. Amsellem-Ouazana D, Younes P, Conquy S, et al. (2005) Negative prostatic biopsies in patients with High risk of prostate cancer. Eur Urol 47:582-586
35. Star-Lack J, Nelson SJ, Kurhanewicz J, et al. (1997) Improved water, lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38:311-321
36. Rifkin MD, Zerhouni EA, Gatsonis CA, et al. (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 323:621-626
37. Outwater EK, Petersen RO, Siegelman ES, et al. (1994) Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333-339
38. Tempany CM, Zhou X, Zerhouni EA, et al. (1994) Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 192:47-54
39. Harris RD, Schned AR, Heaney JA (1995) Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. RadioGraphics 15:813-829
40. Jager JG, Ruijter ET, van de Kaa CA, et al. (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 166:845-850
41. Ung JO, Richie JP, Chen MH, et al. (2002) Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60:458-463
42. Epstein JI (1990) Evaluation of radical prostatectomy capsular margins of resection. Am J Surg Pathol 14:626-632
43. Wang L, Hricak H, Kattan KW, et al. (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597-603
44. Steinberg MD, Sauvageot J, Piantadosi S, et al. (1997) Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21:566-576
45. Zakian KL, Sircar K, Hricak H, et al. (2005) Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234:804-814
46. Kurhanewicz J, Vigneron DB, Hricak H, et al. (1996) Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 200:489-496
47. Parivar F, Hricak H, Shinohara K, et al. (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48:594-599
48. Kurhanewicz J, Vigneron DB, Males RG, et al. (2000) The prostate: magnetic resonance imaging and spectroscopy: present and future. In: Hricak H, Carroll PR (eds) Radiological clinics of North America. W.B. Saunders Co.: Philadelphia, pp 115-138
49. Montironi R, Pomante R, Diamanti L, et al. (1998) Apoptosis in prostatic adenocarcinoma following complete androgen ablation. Urol Int 60:25-29
50. Mueller-Lisse UG, Swanson MG, Vigneron DB, et al. (2001) Hormone ablation of localized prostate cancer: time-dependent therapy effects on prostate metabolism detected by 3D 1H MR spectroscopy. Magn Reson Med 46:49-57
51. Coakley FV, Teh HS, Qayyum A, et al. (2004) Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233:441-448